The US Food and Drug Administration (FDA) is reminding clinicians about the need for "at least yearly, lifelong follow-up" to monitor for type III endoleaks in patients with any type of Endologix AFX ...

For the second time this year, the US Food and Drug Administration has issued a safety communication to healthcare professionals regarding risk of Type III endoleaks associated with Endologix AFX ...

Nectero Medical Inc. has secured $19.5 million in a series C financing round, led by Boston Scientific Corp. The company is developing the Endovascular Aortic Stabilization Treatment (EAST) system, a ...

Please provide your email address to receive an email when new articles are posted on . The FDA Circulatory System Devices Panel of the Medical Devices Advisory Committee voted 11-4 that the benefits ...

That women fare worse than men after treatment for abdominal aortic aneurysm isn’t news, but 10 years’ worth of US registry data show that the difference is long-lasting and appears restricted to ...

Abdominal aortic aneurysm (AAA) is a common and deadly problem. The aortic diameter increases in association with a complex remodeling process that includes changes in the structure and content of key ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Among patients with abdominal aortic ...

—In a new U.S.-based study, a causal relationship was found between risk of abdominal aortic aneurysm (AAA) and elevation in triglyceride-rich lipoproteins and triglyceride metabolism-related proteins ...

“Abdominal Aortic Aneurysm Pipeline Insight, 2020” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Abdominal Aortic ...

Nectero Medical Inc. has secured $19.5 million in a series C financing round, led by Boston Scientific Corp. The company is developing the Endovascular Aortic Stabilization Treatment (EAST) system, a ...